Daniel J. Brennan Receives Stock Award at Vertex Pharmaceuticals Inc MA (VRTX) — SEC Form 4, Oct 22, 2026
SEC Form 4 · No Market Transaction
Stock Award
Compensation grant — no market purchase or sale.
Equity Position
795 sh
0 → 795
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Vertex Pharmaceuticals Inc MA
VRTX
CIK 0000875320
All Vertex Pharmaceuticals Inc MA insider activity
Reporting Owner
| Name | Relationship |
|---|---|
| Daniel J. Brennan CIK 0001595612 |
Director
|
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| Common StockF1 | 2026-10-20 | A - Award/Grant | 795 A | $503.47 | +$400,259 | 795 | Direct |
Footnotes (1)
- F1
- Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date. Show more
Related filings at Vertex Pharmaceuticals Inc MA
Institutional Holders
13F holders · Jun 30, 2026
1,768
institutional managers reporting a position
Largest by reported value
- Capital World Investors $13B
- Black Rock, Inc. $12B
- Capital Research Global Investors $9.68B
5%+ Holders · 13D/G
3 filers
Other insiders at Vertex Pharmaceuticals Inc MA
GET /v1/forms/4/0000875320-26-000283
API docs
View Original SEC Filing